NXTN yields 67.80% · JNJ yields 2.13%● Live data
📍 NXTN pulled ahead of the other in Year 1
Combined, NXTN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXTN + JNJ for your $10,000?
Next10, Inc. engages in the development, manufacture, and sale of security systems for the cargo transportation industry primarily in the United States and Canada. The company offers 'Bulldog Online Security Systems' (BOSS), which is designed to prevent cargo theft from cargo containers, tractor-trailers, cargo vans, tanker trucks, storage year containers, and other cargo transportation and storage equipment. Its products alert onsite security personnel in the event of theft or tampering; alert the driver in the event someone attempts to access the cargo; and monitors multiple roll-up and sliding doors, prevents unauthorized entry and intrusion, and alert the driver through a mobile receiver a thief attempt to enter, move, or remove items from the delivery vehicle. The company's BOSS line of products primarily include The Yard BOSS, The Road BOSS, The Tanker BOSS, Bulldogs BOSS Tracker, and Mini BOSS System. It offers its products to retail, pharmaceutical, high technology, and government markets. The company was formerly known as Bulldog Technologies, Inc. and changed its name to Next10, Inc. on March 25, 2011. Next10, Inc. was incorporated in 1998 and is based in Placentia, California.
Full NXTN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.